Back to top
more

Herbalife Ltd (HLF)

(Delayed Data from NYSE)

$8.51 USD

8.51
2,208,283

+0.14 (1.67%)

Updated Nov 8, 2024 04:00 PM ET

After-Market: $8.50 -0.01 (-0.12%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth C Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 24% (191 out of 251)

Industry: Retail - Pharmacies and Drug Stores

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Herbalife Ltd (HLF) Q3 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

Herbalife Ltd (HLF) delivered earnings and revenue surprises of 200% and 0.67%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Urmimala Biswas headshot

CVS Q3 Estimates Plunge Before Earnings Release: How to Play the Stock

by Urmimala Biswas

CVS Health faces outpatient and supplemental benefits pressure within Health Care Benefits.

Urmimala Biswas headshot

WBA Stock Up 16% on New Restructuring Strategy: How to Play the Stock

by Urmimala Biswas

Walgreens Boots is currently going all out to reform its pharmacy model by aggressively liquidating its unprofitable stores and businesses.

Walgreens Boots Alliance (WBA) Surpasses Q4 Earnings and Revenue Estimates

by Zacks Equity Research

Walgreens (WBA) delivered earnings and revenue surprises of 8.33% and 5.07%, respectively, for the quarter ended August 2024. Do the numbers hold clues to what lies ahead for the stock?

Moumi Mondal headshot

Assessing WBA Before Q4 Earnings: How Should You Play the Stock?

by Moumi Mondal

A challenging retail environment and pharmacy trends are expected to cloud Walgreens' performance in the fourth quarter of fiscal 2024.

Urmimala Biswas headshot

CVS Stock Hits 50-Day SMA on Split Rumors: How Should You Play?

by Urmimala Biswas

The market speculates that following the FTC notice, several investors are pushing CVS Health to go for segment breakups.

Urmimala Biswas headshot

WBA Stock Dips 5% Post Fed Rate Cut: Should You Sell Walgreens Boots?

by Urmimala Biswas

WBA is currently facing challenges within its U.S. Retail Pharmacy segment due to an unfavorable consumer environment and adverse pharmacy industry trends.

Zacks Industry Outlook Highlights CVS Health, Walgreens Boots Alliance, Herbalife and Amazon

by Zacks Equity Research

CVS Health, Walgreens Boots Alliance, Herbalife and Amazon are part of the Zacks Industry Outlook article.

Urmimala Biswas headshot

3 Stocks to Avoid From The Volatile Retail Pharmacy Industry

by Urmimala Biswas

Zacks Retail-Pharmacies and Drug Stores industry players like CVS, WBA and HLF are likely to be affected by reimbursement challenges that are hurting the overall health of the industry.

Urmimala Biswas headshot

CVS Stock Tanks 27.5% Year to Date: Time to Buy the Dip?

by Urmimala Biswas

While CVS Health has been grappling with pharmacy reimbursement pressure, a turnaround might be in the cards, given its several strategic initiatives.

The Zacks Analyst Blog CVS Health, Walgreens and Herbalife

by Zacks Equity Research

CVS Health, Walgreens and Herbalife are included in this Analyst Blog.

Urmimala Biswas headshot

What is the Right Approach for CVS Health (CVS) Post Q2 Results?

by Urmimala Biswas

The near-term challenges for CVS Health (CVS) are no doubt worrisome. Yet, the company remains focused on its strategic moves, utilizing integrated healthcare models and technological advancements.

Herbalife Ltd (HLF) Tops Q2 Earnings Estimates

by Zacks Equity Research

Herbalife Ltd (HLF) delivered earnings and revenue surprises of 25.58% and 3.17%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Urmimala Biswas headshot

CVS Health (CVS) Stock Pre-Q2 Earnings: To Buy or Not to Buy?

by Urmimala Biswas

CVS Health (CVS) is grappling with a sudden increase in Medicare Advantage members' utilization trend. The Medicaid business, too, is expected to have experienced medical cost pressure in the second quarter.

Urmimala Biswas headshot

CVS Health (CVS) Falls 24% in 3 Months: Should You Buy the Dip?

by Urmimala Biswas

While CVS Health (CVS) has been grappling with the pharmacy reimbursement pressure, a turnaround might be in the cards given its several strategic initiatives.

Urmimala Biswas headshot

2 Stocks to Watch & One to Avoid From the Volatile Retail Pharmacy Industry

by Urmimala Biswas

Zacks Retail-Pharmacies and Drug Stores industry players like WBA and HLF are likely to gain despite reimbursement challenges that are hurting the overall health of the industry. CVS might struggle in the face of economic challenges.

Herbalife Ltd (HLF) Q1 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

Herbalife Ltd (HLF) delivered earnings and revenue surprises of 32.43% and 0.66%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Ideas feature highlights: Herbalife and Boeing

by Zacks Equity Research

Herbalife and Boeing have been highlighted in this Investment Ideas article.

Andrew Rocco headshot

Navigate Bearish Markets With This Pattern

by Andrew Rocco

It's critical for investors to recognize bearish patterns to survive downtrending bearish markets. The bear flag pattern is simple and easy to identify, and is the most effective bearish technical pattern.

Zacks Industry Outlook Highlights CVS Health, Walgreens Boots Alliance, Herbalife and Amazon

by Zacks Equity Research

CVS Health, Walgreens Boots Alliance, Herbalife and Amazon have been highlighted in this Industry Outlook article.

Urmimala Biswas headshot

2 Retail Pharmacy Stocks to Watch and One to Avoid Amid Industry Headwinds

by Urmimala Biswas

Zacks Retail-Pharmacies and Drug Stores industry players like CVS and WBA are likely to gain despite reimbursement challenges that are hurting the overall health industry. HLF might face the wrath of economic challenges.

Spotify and Herbalife have been highlighted as Zacks Bull and Bear of the Day

by Zacks Equity Research

Spotify and Herbalife are part of the Zacks Bull and Bear of the Day article.

Andrew Rocco headshot

Bear of the Day: Herbalife (HLF)

by Andrew Rocco

Herbalife's struggles with legal battles, mounting debt, and slowing earnings per share casts a shadow over its future prospects. The company's controversial business model and poor performance suggest ongoing challenges ahead.

Zacks Investment Ideas feature highlights: Coinbase, Super Micro Computer and Herbalife

by Zacks Equity Research

Coinbase, Super Micro Computer and Herbalife have been highlighted in this Investment Ideas article.

Andrew Rocco headshot

Real World vs. Theoretical Investing: Part 2

by Andrew Rocco

Investing in the real-world and investing in theory are worlds apart. Stock Strategist Andrew Rocco provides the details you need to know to succeed and profit in the real-world.